• Consortium DXC; SYMPTOMA; EMODA; NPO - Organización Nacional de Pacientes; CHU Liege; SERGAS; RUBY; UKCM; GRADIANT; FBGS - Fundación Biomédica Galicia Sur.; UM - Universidad de Maribor.; HESSO; UL - Universidad de Letonia.v
  • Funding H2020
  • Opening / Ending January 2020 / February 2023

This is H2020 project aimed at addressing the unmet needs of cancer survivors. In fact PERSIST, will have a transformational impact on the cancer survivor quality of life by ensuring that big data technologies will be prepared to be used routinely throughout the healthcare sector. This way, PERSIST not only will deliver high-quality care while personalizing treatment and survivorship care plans but will also reduce the burdening cancer costs.

 This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406